Journal of the Korean Society of Radiology (대한영상의학회지)

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Interpretation of Rectal MRI after Neoadjuvant Treatment in Patients with Rectal Cancer

수술 전 선행보조치료를 받은 직장암 환자의 직장 자기공명영상의 해석

  • Nieun Seo (Department of Radiology, Severance Hospital, Yonsei University College of Medicine) ;
  • Joon Seok Lim (Department of Radiology, Severance Hospital, Yonsei University College of Medicine)
  • 서니은 (연세대학교 의과대학 영상의학교실) ;
  • 임준석 (연세대학교 의과대학 영상의학교실)
  • Received : 2023.01.19
  • Accepted : 2023.03.14
  • Published : 2023.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

MRI is currently the imaging modality of choice to evaluate rectal cancer after neoadjuvant treatment. The purposes of restaging MRI are to assess the resectability of rectal cancer and to decide whether organ preservation strategies can be applied in patients with a complete clinical response. This review article indicates the key MRI features needed to evaluate rectal cancer after neoadjuvant treatment using a systematic approach. Assessment of primary tumor response including MRI findings to predict a complete response is discussed. Additionally, MRI evaluation of the relationship between the primary tumor and adjacent structures, lymph node response, extramural venous invasion, and tumor deposits after neoadjuvant treatment is presented. Knowledge of these imaging features and their clinical relevance may help radiologists provide an accurate and clinically valuable interpretation of restaging rectal MRI.

자기공명영상은 현재 선행보조치료 후 직장암을 평가할 수 있는 가장 우수한 영상검사이다. 선행보조치료 후 시행하는 직장 자기공명영상의 목적은 직장암의 절제가능성을 평가하고 임상적으로 완전관해로 생각되는 환자들에서 장기 보존 전략을 적용할 수 있게 하는 것이다. 이번 종설에서는 선행보조치료 후 자기공명영상에서 평가해야 할 중요한 소견들을 체계적으로 평가하는 방법을 다루고자 한다. 먼저 원발 종양의 치료 반응을 평가하고, 완전관해를 시사하는 영상 소견에 대해 고찰하고자 한다. 또한 선행보조치료 후 원발 종양과 주변 구조물과의 관계, 임파절, extramural venous invasion, tumor deposit의 소견을 다루고자 한다. 이러한 영상 소견 및 임상적 중요성에 대한 지식은 정확하고 임상적으로 의미 있는 판독을 제공하는데 기여할 것이다.

Keywords

Acknowledgement

Medical Illustration & Design (MID), a part of the Medical Research Support Services of Yonsei University College of Medicine, for providing support with medical illustration.

References

  1. Jung KW, Won YJ, Kang MJ, Kong HJ, Im JS, Seo HG. Prediction of cancer incidence and mortality in Korea, 2022. Cancer Res Treat 2022;54:345-351  https://doi.org/10.4143/crt.2022.179
  2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424  https://doi.org/10.3322/caac.21492
  3. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;1:1479-1482  https://doi.org/10.1016/S0140-6736(86)91510-2
  4. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740  https://doi.org/10.1056/NEJMoa040694
  5. Fokas E, Appelt A, Glynne-Jones R, Beets G, Perez R, Garcia-Aguilar J, et al. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer. Nat Rev Clin Oncol 2021;18:805-816  https://doi.org/10.1038/s41571-021-00538-5
  6. Maas M, Beets-Tan RG, Lambregts DM, Lammering G, Nelemans PJ, Engelen SM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 2011;29:4633-4640  https://doi.org/10.1200/JCO.2011.37.7176
  7. Kong JC, Soucisse M, Michael M, Tie J, Ngan SY, Leong T, et al. Total neoadjuvant therapy in locally advanced rectal cancer: a systematic review and metaanalysis of oncological and operative outcomes. Ann Surg Oncol 2021;28:7476-7486  https://doi.org/10.1245/s10434-021-09837-8
  8. Kasi A, Abbasi S, Handa S, Al-Rajabi R, Saeed A, Baranda J, et al. Total neoadjuvant therapy vs standard therapy in locally advanced rectal cancer: a systematic review and meta-analysis. JAMA Netw Open 2020;3:e2030097 
  9. Cummings BJ, Rider WD, Harwood AR, Keane TJ, Thomas GM. Radical external beam radiation therapy for adenocarcinoma of the rectum. Dis Colon Rectum 1983;26:30-36  https://doi.org/10.1007/BF02554676
  10. Seo N, Kim H, Cho MS, Lim JS. Response assessment with MRI after chemoradiotherapy in rectal cancer: current evidences. Korean J Radiol 2019;20:1003-1018  https://doi.org/10.3348/kjr.2018.0611
  11. Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L, et al. Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 2018;28:1465-1475  https://doi.org/10.1007/s00330-017-5026-2
  12. Almeida RR, Souza D, Matalon SA, Hornick JL, Lee LK, Silverman SG. Rectal MRI after neoadjuvant chemoradiation therapy: a pictorial guide to interpretation. Abdom Radiol (NY) 2021;46:3044-3057  https://doi.org/10.1007/s00261-021-03007-w
  13. Lambregts DMJ, Boellaard TN, Beets-Tan RGH. Response evaluation after neoadjuvant treatment for rectal cancer using modern MR imaging: a pictorial review. Insights Imaging 2019;10:15 
  14. Wnorowski AM, Menias CO, Pickhardt PJ, Kim DH, Hara AK, Lubner MG. Mucin-containing rectal carcinomas: overview of unique clinical and imaging features. AJR Am J Roentgenol 2019;213:26-34  https://doi.org/10.2214/AJR.18.20864
  15. Patel UB, Brown G, Rutten H, West N, Sebag-Montefiore D, Glynne-Jones R, et al. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann Surg Oncol 2012;19:2842-2852  https://doi.org/10.1245/s10434-012-2309-3
  16. Bhoday J, Smith F, Siddiqui MR, Balyasnikova S, Swift RI, Perez R, et al. Magnetic resonance tumor regression grade and residual mucosal abnormality as predictors for pathological complete response in rectal cancer postneoadjuvant chemoradiotherapy. Dis Colon Rectum 2016;59:925-933  https://doi.org/10.1097/DCR.0000000000000667
  17. Patel UB, Taylor F, Blomqvist L, George C, Evans H, Tekkis P, et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol 2011;29:3753-3760  https://doi.org/10.1200/JCO.2011.34.9068
  18. Jang JK, Choi SH, Park SH, Kim KW, Kim HJ, Lee JS, et al. MR tumor regression grade for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy: a systematic review and meta-analysis for accuracy. Eur Radiol 2020;30:2312-2323  https://doi.org/10.1007/s00330-019-06565-2
  19. Battersby NJ, Dattani M, Rao S, Cunningham D, Tait D, Adams R, et al. A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial. Trials 2017;18:394 
  20. Sclafani F, Brown G, Cunningham D, Wotherspoon A, Mendes LST, Balyasnikova S, et al. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer. Br J Cancer 2017;117:1478-1485  https://doi.org/10.1038/bjc.2017.320
  21. Siddiqui MR, Gormly KL, Bhoday J, Balyansikova S, Battersby NJ, Chand M, et al. Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG). Clin Radiol 2016;71:854-862  https://doi.org/10.1016/j.crad.2016.05.005
  22. El Khababi N, Beets-Tan RGH, Tissier R, Lahaye MJ, Maas M, Curvo-Semedo L, et al. Comparison of MRI response evaluation methods in rectal cancer: a multicentre and multireader validation study. Eur Radiol 2022 Dec 28 [Epub]. https://doi.org/10.1007/s00330-022-09342-w 
  23. Kim S, Han K, Seo N, Kim HJ, Kim MJ, Koom WS, et al. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 2018;28:5231-5240  https://doi.org/10.1007/s00330-018-5520-1
  24. Dresen RC, Beets GL, Rutten HJ, Engelen SM, Lahaye MJ, Vliegen RF, et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall? Radiology 2009;252:71-80  https://doi.org/10.1148/radiol.2521081200
  25. Jia X, Zhang Y, Wang Y, Feng C, Shen D, Ye Y, et al. MRI for restaging locally advanced rectal cancer: detailed analysis of discrepancies with the pathologic reference standard. AJR Am J Roentgenol 2019;213:1081-1090  https://doi.org/10.2214/AJR.19.21383
  26. Park SH, Cho SH, Choi SH, Jang JK, Kim MJ, Kim SH, et al. MRI assessment of complete response to preoperative chemoradiation therapy for rectal cancer: 2020 guide for practice from the Korean Society of Abdominal Radiology. Korean J Radiol 2020;21:812-828  https://doi.org/10.3348/kjr.2020.0483
  27. Santiago I, Barata M, Figueiredo N, Pares O, Henriques V, Galzerano A, et al. The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer. Eur Radiol 2020;30:224-238  https://doi.org/10.1007/s00330-019-06348-9
  28. van der Paardt MP, Zagers MB, Beets-Tan RG, Stoker J, Bipat S. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology 2013;269:101-112  https://doi.org/10.1148/radiol.13122833
  29. Lambregts DMJ, Delli Pizzi A, Lahaye MJ, van Griethuysen JJM, Maas M, Beets GL, et al. A pattern-based approach combining tumor morphology on MRI with distinct signal patterns on diffusion-weighted imaging to assess response of rectal tumors after chemoradiotherapy. Dis Colon Rectum 2018;61:328-337  https://doi.org/10.1097/DCR.0000000000000915
  30. Lambregts DM, Vandecaveye V, Barbaro B, Bakers FC, Lambrecht M, Maas M, et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol 2011;18:2224-2231  https://doi.org/10.1245/s10434-011-1607-5
  31. Jang JK, Lee CM, Park SH, Kim JH, Kim J, Lim SB, et al. How to combine diffusion-weighted and T2-weighted imaging for MRI assessment of pathologic complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer? Korean J Radiol 2021;22:1451-1461  https://doi.org/10.3348/kjr.2020.1403
  32. Lee MA, Cho SH, Seo AN, Kim HJ, Shin KM, Kim SH, et al. Modified 3-point MRI-based tumor regression grade incorporating DWI for locally advanced rectal cancer. AJR Am J Roentgenol 2017;209:1247-1255  https://doi.org/10.2214/AJR.16.17242
  33. Horvat N, El Homsi M, Miranda J, Mazaheri Y, Gollub MJ, Paroder V. Rectal MRI interpretation after neoadjuvant therapy. J Magn Reson Imaging 2023;57:353-369  https://doi.org/10.1002/jmri.28426
  34. van Griethuysen JJM, Bus EM, Hauptmann M, Lahaye MJ, Maas M, Ter Beek LC, et al. Gas-induced susceptibility artefacts on diffusion-weighted MRI of the rectum at 1.5 T - Effect of applying a micro-enema to improve image quality. Eur J Radiol 2018;99:131-137  https://doi.org/10.1016/j.ejrad.2017.12.020
  35. Taylor FG, Quirke P, Heald RJ, Moran BJ, Blomqvist L, Swift IR, et al. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. J Clin Oncol 2014;32:34-43  https://doi.org/10.1200/JCO.2012.45.3258
  36. Benson AB, Venook AP, Al-Hawary MM, Azad N, Chen YJ, Ciombor KK, et al. Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2022;20:1139-1167  https://doi.org/10.6004/jnccn.2022.0051
  37. Vliegen RF, Beets GL, Lammering G, Dresen RC, Rutten HJ, Kessels AG, et al. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction. Radiology 2008;246:454-462  https://doi.org/10.1148/radiol.2462070042
  38. Kulkarni T, Gollins S, Maw A, Hobson P, Byrne R, Widdowson D. Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status. Colorectal Dis 2008;10:479-489  https://doi.org/10.1111/j.1463-1318.2007.01451.x
  39. Yuval JB, Thompson HM, Firat C, Verheij FS, Widmar M, Wei IH, et al. MRI at restaging after neoadjuvant therapy for rectal cancer overestimates circumferential resection margin proximity as determined by comparison with whole-mount pathology. Dis Colon Rectum 2022;65:489-496  https://doi.org/10.1097/DCR.0000000000002145
  40. Park MJ, Kim SH, Lee SJ, Jang KM, Rhim H. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. Radiology 2011;260:771-780  https://doi.org/10.1148/radiol.11102135
  41. Kim KH, Park MJ, Lim JS, Kim NK, Min BS, Ahn JB, et al. Circumferential resection margin positivity after preoperative chemoradiotherapy based on magnetic resonance imaging for locally advanced rectal cancer: implication of boost radiotherapy to the involved mesorectal fascia. Jpn J Clin Oncol 2016;46:316-322  https://doi.org/10.1093/jjco/hyv208
  42. Lahaye MJ, Beets GL, Engelen SM, Kessels AG, de Bruine AP, Kwee HW, et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes? Radiology 2009;252:81-91  https://doi.org/10.1148/radiol.2521081364
  43. Perez RO, Pereira DD, Proscurshim I, Gama-Rodrigues J, Rawet V, Sao Juliao GP, et al. Lymph node size in rectal cancer following neoadjuvant chemoradiation--can we rely on radiologic nodal staging after chemoradiation? Dis Colon Rectum 2009;52:1278-1284  https://doi.org/10.1007/DCR.0b013e3181a0af4b
  44. Santiago I, Rodrigues B, Barata M, Figueiredo N, Fernandez L, Galzerano A, et al. Re-staging and follow-up of rectal cancer patients with MR imaging when "watch-and-wait" is an option: a practical guide. Insights Imaging 2021;12:114 
  45. Ogura A, Konishi T, Beets GL, Cunningham C, Garcia-Aguilar J, Iversen H, et al. Lateral nodal features on restaging magnetic resonance imaging associated with lateral local recurrence in low rectal cancer after neoadjuvant chemoradiotherapy or radiotherapy. JAMA Surg 2019;154:e192172 
  46. Schaap DP, Boogerd LSF, Konishi T, Cunningham C, Ogura A, Garcia-Aguilar J, et al. Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes. Br J Surg 2021;108:205-213  https://doi.org/10.1093/bjs/znaa009
  47. Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2008;95:229-236  https://doi.org/10.1002/bjs.5917
  48. Rouleau Fournier F, Motamedi MAK, Brown CJ, Phang T, Raval MJ, Hague CJ, et al. Oncologic outcomes associated with MRI-detected extramural venous invasion (mrEMVI) in rectal cancer: a systematic review and meta-analysis. Ann Surg 2022;275:303-314  https://doi.org/10.1097/SLA.0000000000004636
  49. Chen S, Li N, Tang Y, Shi J, Zhao Y, Ma H, et al. The prognostic value of MRI-detected extramural vascular invasion (mrEMVI) for rectal cancer patients treated with neoadjuvant therapy: a meta-analysis. Eur Radiol 2021;31:8827-8837  https://doi.org/10.1007/s00330-021-07981-z
  50. Tan JJ, Carten RV, Babiker A, Abulafi M, Lord AC, Brown G. Prognostic importance of MRI-detected extramural venous invasion in rectal cancer: a literature review and systematic meta-analysis. Int J Radiat Oncol Biol Phys 2021;111:385-394  https://doi.org/10.1016/j.ijrobp.2021.05.136
  51. Chand M, Swift RI, Tekkis PP, Chau I, Brown G. Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br J Cancer 2014;110:19-25  https://doi.org/10.1038/bjc.2013.603
  52. Fornell-Perez R, Vivas-Escalona V, Aranda-Sanchez J, Gonzalez-Dominguez MC, Rubio-Garcia J, Aleman-Flores P, et al. Primary and post-chemoradiotherapy MRI detection of extramural venous invasion in rectal cancer: the role of diffusion-weighted imaging. Radiol Med 2020;125:522-530  https://doi.org/10.1007/s11547-020-01137-7
  53. Nagtegaal ID, Tot T, Jayne DG, McShane P, Nihlberg A, Marshall HC, et al. Lymph nodes, tumor deposits, and TNM: are we getting better? J Clin Oncol 2011;29:2487-2492  https://doi.org/10.1200/JCO.2011.34.6429
  54. Lord AC, D'Souza N, Shaw A, Rokan Z, Moran B, Abulafi M, et al. MRI-diagnosed tumor deposits and EMVI status have superior prognostic accuracy to current clinical TNM staging in rectal cancer. Ann Surg 2022;276:334-344  https://doi.org/10.1097/SLA.0000000000004499
  55. Chandramohan A, Mittal R, Dsouza R, Yezzaji H, Eapen A, Simon B, et al. Prognostic significance of MR identified EMVI, tumour deposits, mesorectal nodes and pelvic side wall disease in locally advanced rectal cancer. Colorectal Dis 2022;24:428-438  https://doi.org/10.1111/codi.16032
  56. Lord AC, Moran B, Abulafi M, Rasheed S, Nagtegaal ID, Terlizzo M, et al. Can extranodal tumour deposits be diagnosed on MRI? Protocol for a multicentre clinical trial (the COMET trial). BMJ Open 2020;10:e033395